Brief: Pulmatrix And Sensory Cloud Announce Partnership To Develop And Commercialize A Potential Nasal Prophylactic And Anticontagion Product For Covid-19

Pulmatrix

16/04/2020 13:41

April 16 (Reuters) - Pulmatrix Inc  PULM.O :
    * PULMATRIX AND SENSORY CLOUD ANNOUNCE PARTNERSHIP TO
DEVELOP AND
COMMERCIALIZE A POTENTIAL NASAL PROPHYLACTIC AND ANTICONTAGION
PRODUCT FOR COVID-19
    * PULMATRIX INC - WILL OUT-LICENSE INTELLECTUAL PROPERTY OF
NASOCALM TO SENSORY CLOUD FOR WORLDWIDE DISTRIBUTION,
COMMERCIALIZATION AND MARKETING
    * PULMATRIX- SHALL BE ENTITLED TO RECEIVE A MILESTONE
PAYMENT OF
$1 MILLION FOLLOWING ACHIEVEMENT OF AGGREGATE NET SALES OF ALL
LICENSED PRODUCTS OF $20 MILLION

Source text for Eikon:  ID:nPn2C0RVHa 
Further company coverage:  PULM.O 

 ((Reuters.Briefs@thomsonreuters.com;))